Caeruloplasmin: Physiological and Pathological Perspectives

References

• Neilands J. B. Microbial iron transporting compounds (siderochromes), chap. 5. Inorganic Biochemistry, G. Eichhorn. Elsevier, Amsterdam 1973
   Google Scholar
• Raymond K. N., Carrano C. J. Coordination chemistry and microbial iron transport. Acc. Chem. Res. 1979; 12: 183
   Web of Science ®Google Scholar
• Calvin M. Chem. Evol. Clarendon Press, Oxford 1969; 146
   Google Scholar
• Frieden E. The evolution of metals as essential elements (with special reference to iron and copper). Protein-Metal Interactions, M. Friedman. Plenum Press, New York 1974; 1
   Google Scholar
• Frieden E. J. Copper and iron metalloproteins. Trends Eiochem. Sci. 1976; 1: 273
   Google Scholar
• Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979; 59: 527
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M. C. Iron-oxygen reactions and their use in clinical chemistry. Med. Lab. Sci. 1981; 31: 267
   Google Scholar
• McCord J. M., Fridovitch I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969; 244: 6049
   PubMed Web of Science ®Google Scholar
• Fridovitch I. Superoxide and superoxide dismutasa, chap. 2. Advances in Inorganic Biochemistry, G. Eichhorn, L. G. Mamlli. Elsevier, North-Holland, New York 1979
   Google Scholar
• Halliwell B. Free radicals, oxygen toxicity and ageing. Age Pigments, R. S. Sohal. Elsevier, Amsterdam, in press
   Google Scholar
• Frieden E., Osaki S. Caeruloplasmin: a possible missing link between copper and iron metabolism, chap. 3. Effects of Metals on Cells. Subcellular Elements., and Macromolecules, J. Maniloff, J. R. Coleman, M. W. Miller. Charles C Thomas, Springfield, III. 1970
   Google Scholar
• Osaki S., Johnson D. A., Frieden E. The possible significance of the ferrous oxidase activity of caeruloplasmin in normal human serum. J. Biol. Chem. 1966; 241: 2746
   PubMed Web of Science ®Google Scholar
• Holmberg C. G., Laurell C. B., frienden E. The possible significance of the ferrous oxidase activity of caeruloplasmin in normal human serum. J. Biol. chem. 1965; 241: 2746
   Google Scholar
• Kasper E. B., Deutsch H. F. Physiochemical studies of human caeruloplasmin. J. Biol. Chem. 1963; 283: 2325
   Google Scholar
• Poillon W. N., Bearn A. G. The molecular structure of human caeruloplasmin: evidence for subunits. Biochem. Biophys. Act. 1966; 127: 407
   PubMedGoogle Scholar
• Pederson K. O. Molecurlar weights of the proteins. Les Proteines: Rapports et Discusions, R. Stoops. Inst. Inter. Chim. Solvay, Neuvieme Counceil de Chimie, BrusselsBelgium 1953; 19
   Google Scholar
• Magdoff-Fairchild B., Lovell F. M., Low B. W. An x-ray crystallographic study of caeruloplasmin. J. Biol Chem. 1969; 244: 3497
   PubMed Web of Science ®Google Scholar
• Ryden L. Single-chain structure of human caeruloplasmin. Eur. J. Biochem. 1972; 26: 380
   PubMedGoogle Scholar
• Freeman S., Daniel E. Dissociation and reconstitution of human caeruloplasmin. Biochemistry 1973; 12: 4806
   PubMedGoogle Scholar
• Lowenstein H. Immunochemical investigation on human caeruloplasmin. Partial explanation of the heterogeneity. Int. J. Protein Res. 1975; 7: 1
   Google Scholar
• Nakagawa O. Purification and properties of crystalline human caeruloplasmin. Int: J. Protein Res. 1972; 4: 345
   Google Scholar
• Deinum J., Vanngard T. The stoichimetry of the paramagnetic copper and the oxidation—reduction potentials of type I copper in human caeruloplasmin. Biochem. Biophys. Acta 1973; 310: 321
   PubMedGoogle Scholar
• Byers W., Curzon G., Garbett K., Speyer B. E., Young S. N., Williams R. J. P. Anion-binding and the state of copper in caeruloplasmin. Biochem. Biophys. Acta 1973; 310: 38
   PubMedGoogle Scholar
• Ryden L., Bjork I. Reinvestigation of some physicochemical and chemical properties of human caeruloplasmin (ferroxidase). Biochemistry 1976; 15: 3411
   PubMed Web of Science ®Google Scholar
• Damashun G., Damsashun K. H., Kayushina R. L., Kreber R., Moshkov K. A., Muller J., Neifakh S. A., Purschel H., Shavlouskii M. M., Belke J. Determination of the molecular weight of human caeruloplasmin using hydrodynamic methods and low-angle X-ray scatter. Biofizika 1976; 21: 965
   PubMedGoogle Scholar
• Moshkov K. A., Shavlovski M. M., Zaitzeh V. N., Neifakh S. A. Preliminary X-ray crystallographic and physico-chemical investigations of human careruloplasmin. Int. J. Protein Res. 1977; 9: 187
   Google Scholar
• Kasper C. B. Limited trypsin-catalyzed hydrolysis human caeruloplasmin, partial caharacterization of the digest. Biochemistry 1965; 6: 3185
   Google Scholar
• Scheinberg L. H., Morell A. G. Caeruloplasmin. Inorganic Biochemistry, G. L. Eichhorn. Elsevier, Amsterdam 1973; Vol. 1: 10
   Google Scholar
• Heimburger N., Heide K., Haupt H., Schultze H. E. Baustein analysen von humanserumproteinen. Clin. Chim. Acta 1964; 10: 293
   PubMedGoogle Scholar
• Briving C., Deinum J. Sulfhydryl groups, disulfide bridges and the state of copper in three blue oxidases. FEBS Lett. 1975; 51: 43
   PubMedGoogle Scholar
• Witwicki J., Zahrzewski K. Sulfhydryl groups in human caeruloplasmin. Eur. J. Biochem. 1969; 10: 284
   PubMedGoogle Scholar
• Bannister W. H., Wood E. J. Effect of photoxidation on human caeruloplasmin. Eur. J. Biochem. 1969; 11: 179
   PubMedGoogle Scholar
• Nylen V., Pettersson G. The effect of diethylpyrocarbonate on some physical and chemical properties of caeruloplasmin. Eur. J. Biochem. 1972; 27: 578
   PubMedGoogle Scholar
• Schultz H. E., Schwick G. Quantitative immunologishe bestimmung von plasmaprotein. Clin. Chim. Acta 1959; 4: 15
   PubMedGoogle Scholar
• Jamieson G. A. Studies on glycoproteins, I. The carbohydrate protion of human caeruloplasmin. J. Biol. Chem. 1965; 240: 2019
   PubMedGoogle Scholar
• Holtzman N. A., Naughton M. A., Iber F. L., Gaumnitz B. M. Caeruloplasmin in Wilson's disease. J. Clin, Invest. 1967; 46: 993
   PubMed Web of Science ®Google Scholar
• Morell A. G., Van Den Hamer C. J. A., Scheinberg I. H., Ashwell G. Physical and chemical studies on caeruloplasmin. IV. Preparation of radioactive, sialic acid-free caeruloplasmin labeled with tritium on terminal D-Galctose residues. J. Biol. Chem. 1966; 241: 3745
   PubMed Web of Science ®Google Scholar
• Morell A. G., Sternlieb I., Scheinberg I. H. Physical and chemical studies on caeruloplasmin: crystallization of desialized human caeruloplasmin asialoceruloplasmin. Science 1969; 166: 1293
   PubMedGoogle Scholar
• Morell A. G., Van Den Hamer C. J. A., Schienberg I. H. Physical and chemical studies on caeruloplasmin. IV. Preparation of human caeruloplasmin crystals. J. Biol. Chem. 1969; 244: 3494
   PubMedGoogle Scholar
• Morell A. G., Irvine R. A., Sternlieb I., Scheinberg I. H., Ashwell G. Physical and chemical studies on caeruloplasmin. Metabolic studies on sialic acid-free caeruloplasmin in vivo. J. Biol. Chem. 1968; 243: 155
   PubMed Web of Science ®Google Scholar
• Hickman J., Ashwell G., Morell A. G., Van den Hamer C. J. A., Scheinberg I. H. Physical and chemical studies on caeruloplasmin VIII. Preparation of N-acetylneuraminc acid-1-14 C-labelled caeruloplasmin. J. Biol. Chem. 1970; 245: 759
   PubMed Web of Science ®Google Scholar
• Van Den Hamer C. J. A., Morell A. G., Scheinberg I. H., Hickman J., Ashwell G. Physical and chemical studies on caeruloplasmin. IX. The role of galactosyl residues in the clearance of caeruloplasmin in the liver. J. Biol. Chem. 1970; 245: 5833
   PubMedGoogle Scholar
• Gregoriadis G., Morell A. G., Sternlieb I. H. Catabolism of desialylated caeruloplasmin in the liver. J. Biol. Chem. 1970; 245: 5833
   PubMed Web of Science ®Google Scholar
• Morell A. G., Gregoriadis G., Scheinberg H. The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem. 1971; 246: 1461
   PubMed Web of Science ®Google Scholar
• Nelsestuen G. L., Suttie J. W. Properties of asialo acid and aglycoprothrombin. Biochem. Biophys. Res. Commun. 1971; 45: 198
   PubMedGoogle Scholar
• Briggs D. W., Fisher J. W., George J. W., George J. W. Hepatic clearance of intact and desialyated erythropoietin. Am. J. Physiol. 1974; 227: 1385
   PubMedGoogle Scholar
• Ashwell G., Morell A. G., Morell A. G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv. Enzymol. 1974; 41: 99
   PubMedGoogle Scholar
• Bocci V. The role of sialic acid in determining the life-span of circulating cells and glycoproteins. Experientia 1976; 32: 135
   PubMedGoogle Scholar
• Regoeczi E., Hatton M. W. C., Wong K. L. Studies of the metabolosm of asialotransferrins: poternation of the catabolism of human asialotransferrin in the rabbit. Can. J. Biochem. 1974; 52: 155
   PubMedGoogle Scholar
• Soria J., Soria C., Samama M., Mester L. Influence of human caeruloplasmin on the aggregation of human platelets by adenosine diphosphate. Thrombosis Res. 1974; 4: 327
   PubMedGoogle Scholar
• Schied A., Choppin P. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of sendai virus. virology 1974; 57: 475
   PubMedGoogle Scholar
• Laurell A. B. Inhibitor capacity of some purified human serum proteins on hemagglutination by influenza virus. Acta Pathol. Microbiol. Scand. 1960; 49: 213
   PubMedGoogle Scholar
• Samuel I., Tomas E. Effect of caeruloplasmin on Sendai virus multiplication in chorioallantoic membrane fragment. Rev. Roum. Med. Virol. 1975; 26: 117
   Google Scholar
• Samuel I., Tomas E. Effects and mechanisms of the interaction between caeruloplasmin and some viruses or subviral components. Rev. Roum. Med. Virol. 1978; 29: 129
   Google Scholar
• Tomas E., Samuel I. Interaction between caeruloplasmin and Sendai virus envelope components. VI. Effect of caeruloplasmin on the antigenictiy of sendai virus and Subviral fractions. Rev. Roum. Med. Virol. 1978; 29: 53
   Google Scholar
• Samuel I., Tomas E., Birnawe F. The effect of rat and rabbit caeruloplasmin on the multiplication of two influenza virus strains in the chorioallantoic membrane of embryonated hen eggs. Rev. Roum. Med. Virol. 1978; 29: 301
   Google Scholar
• Tomas E., Samuel I. The effect of some drugs and of caeruloplasmin on experimental influenza APR 8/34 (HONI) infection in the mouse. Rev. Roum. Med. Virol. 1976; 30: 233
   Google Scholar
• Poulik M. D. Electrophoretic and immunological studies on structural sub-units of human caeruloplasmin. Nature (London) 1962; 194: 842
   PubMedGoogle Scholar
• Poulik M. D. Heterogeneity and structure of caeruloplasmin. Ann. N. Y. Acad. Sci. 1968; 151: 476
   PubMedGoogle Scholar
• Simons K., Bearn A. G. Isolation and partial characterization of the polypeptide chains in human caeruloplasmin. Biochem. Biophys. Acta 1969; 175: 260
   PubMedGoogle Scholar
• Kasper C. B., Deutsch A. F. Immunochemical studies of crystalline human caeruloplasmin and derivatives. J. Biol. Chem. 1963; 238: 2343
   PubMedGoogle Scholar
• Ryden L. Evidence for proteolytic fragments in commercial samples of human caeruloplasmin. FEBS lett. 1971; 18: 321
   PubMedGoogle Scholar
• Ryden L. Comparison of polypeptide-chain structure of four mammalian caeruloplasmin by gel filtration in guanidine hydrochloride solutions. Eur. J. Biochem. 1972; 28: 46
   PubMedGoogle Scholar
• McCombs M. L., Bowman B. H. Biochemical studies of human caeruloplasmin. Biochem. Biophys. Acta 1976; 434: 452
   PubMedGoogle Scholar
• Kingston B., Kingston B. L., Putnam F. W. Chemical evidence that Proteolytic cleavage cause the heterogeneity present in human caeruloplasm in preparations. Proc. Nat. Acad. Sci. U. S. 1977; 74: 5377
   PubMed Web of Science ®Google Scholar
• Samsonidze T. G., Moshkov K. A., Kiselov N. A., Neifakh S. A. Electron microscope study on human caeruloplasmin. Int. J. Protein Res. 1979; 14: 161
   Google Scholar
• Broman L. Separation and characterization of two caeruloplasmins form human serum. Nature (Landon) 1958; 182: 1655
   PubMedGoogle Scholar
• Deutsch H. F., Fisher G. B. Studies of human caeruloplasmin fractions seperated by chromatography on hydroxylapatite. J. Biol. chem. 1964; 239: 3325
   PubMedGoogle Scholar
• Hirschmann S. Z., Morell A. G., Scheinberg I. H. The heterogeneity of the copper-containing protein of human plasma, caeruloplasmin. Ann. N. Y. Acad. Sci. 1961; 94: 960
   PubMedGoogle Scholar
• Richterich R., Gautier E., Stillhart H., Rossi E. The herterogeneity of caeruloplasmin and the enzmatic defect in Wilson's disease. Helv. Paediatr. Acad 1960; 15: 424
   PubMedGoogle Scholar
• Broman L. Chromatographic and magnetic studies on human caeruloplasmin. Act. Soc. Med. Upsal. 1964; 69(suppl. 7)
   PubMedGoogle Scholar
• Ryden L. Human caeruloplasmin as a polymorphic glycoprotein. Tryptic glycopeptides from two forms of the Protein. Int. J. Prot. Res. 1971; 3: 131
   PubMedGoogle Scholar
• Ryden L. Human caeruloplasmin as a polymorphic glycoprotein: analysis by chromatography on hydroxyapatite. Int. J. Prot. Res. 1971; 3: 131
   PubMedGoogle Scholar
• Shreffler D. C., Brewer G. J., Gall J. C., Honeyman M. S. Electrophoretic variations in human serum caeruloplasmin. A new genetic polymorphism. Biochem. Genet. 1967; 1: 101
   PubMedGoogle Scholar
• Shokeir M. H. K., Rucknagal D. L., Shreffler D. C., Na-Nakorn S., Wasi P. Genetic polymorphism of human serum caeruloplasmin in Thailand. Am. Soc. Hum. Genet. Abstr. 1968; 21: 68
   Google Scholar
• Shokeir M. H. K., Shreffler D. C. Two new caeruloplasmin variants in negroes: data on three populations. Biochemical Genet. 1970; 4: 517
   PubMedGoogle Scholar
• Shokeir M. H. K. Biochemical and immunological characterization of caeruloplasmin genetic genetic variants. Genetics 1971; 2: 41
   Google Scholar
• Poulik M. D., Weiss M. L. Caeruloplasmin. The plasma proteins2nd ed., E. W. Putnam. Academic Press, New York 1975; Vol. 2
   Google Scholar
• Holmberg C. G., Laurell C. B. Investigations in serun copper. containing protein, and a description of its Properties. Act Chem. Scand. 1948; 2: 550
   Google Scholar
• Aisen P., Koening S. H., Lilienthal H. R. Low temperature magnetic susceptability of caeruloplasmin. J. Mol. Biol. 1967; 28: 225
   PubMedGoogle Scholar
• Deutsch H. F. The preparation of crystalline caeruloplasmin form human plasma. Arch. Biochem. Biophys. 1960; 89: 225
   PubMedGoogle Scholar
• Fee J. A. Copper proteins. Systems containing the blue copper center. Structure and Bonding, J. D. Dunitz, P. Hemmerich. Springer-Verlag, New York 1975; Vol. 23
   Google Scholar
• Ehrenberg A., Malmstrom B. G., Broman L., Mosbach R. A magnetic susceptibility study of copper valence in caeruloplasmin and laccase. J. Mol. Biol. 1962; 5: 450
   Google Scholar
• Huber C. T., Frienden E. Substrate activation and the kinetics of ferroxidase. J. Biol. Chem. 1970; 245: 3973
   PubMed Web of Science ®Google Scholar
• McKee D., Frienden E. Binding of transition metal ions by caeruloplasmin (ferroxidase). Biochemistry 1971; 10: 3880
   PubMedGoogle Scholar
• Broman L., Malmstrom B. G., Aasa R., Vanngard T. Quantitive electron spin resonance studies on native and denatured caeruloplasmin and lasccase. J. Mol. Biol. 1962; 5: 301
   PubMedGoogle Scholar
• Kasper C. B., Deutsch H. F., Beinert H. Studies on the state of copper in native and modified human caeruloplasmin. J. Biol. Chem. 1963; 238: 2338
   PubMedGoogle Scholar
• Blumberg W. E., Eisinger J., Asien P., Morell A. G., Scheinberg I. H. Physical and chemical studies on caeruloplasmin. I. The relation between blue color and the valence states of copper. J. Biol. Chem. 1963; 238: 675
   Google Scholar
• Fee J. A., Malkin R., Malmstrom B. G., Vanngrad T. Anaerobic oxdiation-reduction titrations of fungal laccase. Evidence for several high potential electron-accepting sites. J. Biol. Chem. 1969; 244: 4200
   PubMedGoogle Scholar
• Malkin R., Malmstrom B. G. The state and function of copper. Biological Systems in Advances in Enzymology, F. F. Nord. Interscience, New York 1970; Vol. 33: 177
   Google Scholar
• Renihammare B. The copper-containing oxidases, chap. 3. Advances in Biochemistry, G. Eichhorn, L. G. Marzilli. Eklsevier/North-Holland, New York 1979
   Google Scholar
• Malkin R. The copper-containing oxidases, chap. 21. Inorg. Biochem, G. L. Eichhorn. Eklsevier, New York 1973; Vol. 2
   Google Scholar
• Malmstrom B. C. Some aspects of structure and function in copper containing oxidases, chap. 3. New Trends in Bio-Inorg. Chem, R. J. P. Williams, J. R. R. F. Da Silva. Academic Press, London 1973
   Google Scholar
• Holwerda R. A., Wherland S., Gray H. B. Electron transfer reactions of copper proteins. Ann. Rev. Biophys. Bioeng. 1976; 5: 363
   PubMedGoogle Scholar
• Scheinberg I. H. Caeruloplasmin a review. Biochemistry of Copper, J. Peisach, P. Aisen, W. E. Blumberg. Academic Press, New York 1966
   Google Scholar
• Andreasson L. E., Vanngrad T. Evidence of a specific copper II. in human caeruloplasmin as a binding site for inhibitory anions. Biochem. Biophys. Acta 1970; 200: 247
   PubMedGoogle Scholar
• Veldsema A., VanGelder B. F. The ratio of Type—1 and—2 Cu (II) in human caeruloplasmin. Biochem. Biophys. Acta. 1973; 293: 322
   PubMedGoogle Scholar
• Gunnarasson P. O., Nylen V., Pettersson G. Effect of pH on electron-paramagnetic-resonance spectra of caeruloplasmin. Eur. J. Biochem. Biophys. Acta 1973; 37: 47
   Google Scholar
• Deley M., Osaki S. Interamolecular electron transport in human ferroxidase (caeruloplasmin). Biochem. J. 1975; 151: 561
   PubMedGoogle Scholar
• vanngard T. Some properties of caeruloplasmin copper as studees by ESR spectroscopy in magnetic resonance. Biological Systems, A. Ehrenberg, B. G. Malmstrom, T. Vanngard. Pergamon Press, Oxford 1967; 213
   Google Scholar
• Osaki, Walaas O. Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase. J. Biol. Chem. 1967; 242: 2653
   PubMed Web of Science ®Google Scholar
• Carrico R. J., Malmstrom B. G., Vanngard T. Anaerobic oxidation — reduction titrations of human caeruloplasmin. Evidence for diamagnetic electron — acceptors in the protein. Eur. J. Biochem. 1971; 20: 518
   PubMedGoogle Scholar
• McDermott J. A., Huber C. T., Osaki S., Frieden E. Role of in the oxidase activity. Clin. Chem. 1958; 4: 519
   PubMedGoogle Scholar
• Houchin O. B. A rapid colorimaetric method for quantitative determination of copper oxidase activity. Clin. Chem. 1958; 4: 519
   PubMed Web of Science ®Google Scholar
• Kolb E. Untersuchungen uber das Vorkommen von polyphenol Oxydase and Monoaminoxydase in serum und in Organen vom Pferd. Zentralbl. Veterinarmedizin 1957; 4: 265
   Google Scholar
• Schacter B. Serum catecholose. J. Biol. Chem. 1950; 184: 697
   PubMedGoogle Scholar
• Bakwin R. M., Mosbach E. H., Bakwin H. Caeruloplasmin activity in the serun of children with schizopherenia pediatrics 1958; 22: 905
   PubMedGoogle Scholar
• Humoller F. L., Majka F. A., Barak A. J., Stevens J. D., Holkhams J. M. Determination of plasma amice oxidase activity. Clin. Chem. 1958; 4: 1
   PubMedGoogle Scholar
• Young S. N., Curzon G. A method for obtaining linger reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameter of caeruloplasmin substrates. Biochem. J. 1972; 129: 273
   PubMedGoogle Scholar
• Frieden E., Hsieh H. S. Caeruloplasmin: the copper transport protein with essential oxidase activity. Advances in Enzymology, A. Meister. john Wiley & Sons, London 1976; Vol. 44
   Google Scholar
• Humoller F. L., Mockler M. P., Holthams J. M., Mahler D. J. Enzymatice properties of caeruloplasmin. J. Clin. Lab. Med. 1960; 56: 222
   Google Scholar
• Gunnarsson P. O., Nylen V., Pettersson G. Kinetics of the interaction between caeruloplasmin and reducing substrates. Eur. J. Biochem. 1973; 37: 41
   PubMedGoogle Scholar
• Morell A. G., Aisen P., Scheinberg L. H. Is caeruloplasmin an ascorbic oxidase?. J. Biol. Chem. 1962; 237: 3455
   Google Scholar
• Osaki S., McDermott J. A., Frienden E. Prof for the ascorbate oxidase activity of caeruloplasmin. J. Biol. Chem. 1964; 239: 3570
   PubMed Web of Science ®Google Scholar
• Albergoni V., Cassini M. The oxidation of cysteine by caeruloplasmin. FEBS Lett. 1975; 55: 261
   PubMedGoogle Scholar
• Curzon G. The effects of some ions and chelating agents on the oxidase activity of caeruloplasmin. Biochem. J. 1960; 77: 66
   PubMedGoogle Scholar
• Curzon G. The inhibition of caeruloplasmin by azide. Biochem. J. 1966; 100: 295
   PubMedGoogle Scholar
• Curzon G. The oxidaiton of N', N-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem. J. 1967; 103: 289
   PubMedGoogle Scholar
• Curzon G., Speyer B. F. Inhibitors of caeruloplasmin. Biochem. J. 1967; 105: 243
   PubMedGoogle Scholar
• Levine W. G., Peisach J. Ethylenediaminetetracetate, iorn and caeruloplasmin activity. Biochem. Biophys. Acta 1963; 77: 602
   Google Scholar
• Holmberg C. G., Laurell C. B. Investigations on serum copper III. Caeruloplasmin as an enzyme. Acta. Chem. Scand. 1951; 5: 921
   Google Scholar
• Imoto T., Akasaka K., Hatano H. Nuclear magnetic resonance studies on the interaction between salicylate and caeruloplasmin. FEBS Lett. 1971; 15: 149
   PubMedGoogle Scholar
• Harper H. A. Physiol. Chem.16th ed., H. A. Hapert, V. W. Rodwell, P. A. Mayes. Lange, Los Altos, Calif. 1975
   Google Scholar
• Frieden E., Osaki S. Ferroxidases and ferrireductases: their role in iron metabolism. Med. Biol. 1974; 48: 235
   Google Scholar
• Manis J. Ferrous iron oxidation by intestinal mucosa: possible role in mucosal iron metabolism. Proc. Soc. Exp. Biol. Med. 1973; 144: 1025
   PubMed Web of Science ®Google Scholar
• Michaelis L., Coryell C. D., Granick S. The magnetic properties of ferritin and some other colloidal ferric compounds. J. Biol. Chem. 1943; 148: 463
   Google Scholar
• Tanaka S. A study of ferritin: on the liberation of iron from ferritin. J. Biochem. (Jpn.) 1950; 37: 129
   Google Scholar
• Green S., Mazur A. Relation of uric acid metabolism to release of iron from hepatic ferritin. J. Biol. Chem. 1957; 227: 653
   Web of Science ®Google Scholar
• Mazur A., Green S., Saha A., Charlton A. Mechanism of release of ferritin iron in vivo by xanthine oxidase. J. Clin. Invest. 1958; 37: 1809
   PubMed Web of Science ®Google Scholar
• Mazur A., Carlton A. Hepatic xanthine oxidase and ferritin in the developing rat. Blood 1965; 26: 317
   PubMedGoogle Scholar
• Kozma C., Salvador R. A., Elion G. B. Allopurinol and iron storage. Lnncet. 1967; 2: 1040
   Google Scholar
• Grace N. D., Greenwold M. A., Greenberg M. S. Effect of allopurinol on iron mobilization. Gatroenteroloty 1970; 59: 103
   PubMedGoogle Scholar
• Osaki S., Sirivech S. Identification and partial purification of ferritin reducing enzyme in liver. Fed. Proc. Fed. Am. SOC. Ewp. Biol. 1971; 30: 1292, (Abstr.)
   Google Scholar
• Sirivech S., Frieden E., Osaki S. The release of iron from horse spleen ferritin by reduced flavins. Biochem. J. 1974; 143: 311
   PubMed Web of Science ®Google Scholar
• Frieden E., Aisen P. Forms of iron transferrin. Trends Biochem. Sci. 1980; 5: 11
   Google Scholar
• Aisen P. The transferrins (siderophilins), chap. 9. Inorganic Biochemisiry, G. L. Eichhorn. Elsevier, New York 1973; Vol. I
   Google Scholar
• Aisen P., Brown E. B. The iron-binding function of transferrin in iron metabolism. Semin. in Haemarol. 1977; 14: 31
   PubMed Web of Science ®Google Scholar
• Hart E. B., Steenbock H., Waddell J., Elvehjem C. A. Iron in nutrition. VII. Copper as a supplement to iron for haemoglobin building in the rat. J. Biol. Chem. 1928; 77: 797
   Google Scholar
• Hendrych F., Mori S. Die Bedingungen der Oxydation des Eisens im Blute. Arch Exp. Poth. Pharmak. 1933; 172: 1
   Google Scholar
• Starkenstein E., Harvalik Z. Uber eine im Intermediaren Eisensloffwechsel Entstehende Ferriglobulinverbindung. Arch. Exp. Path. Pharmak. 1933; 172: 75
   Google Scholar
• Koechlin B. A. Preparation and properties of serum and plasma proteins, XXVIII. The β, metalcombining protein of human plasma. J. Am. Chem. Soc. 1952; 74: 2649
   Google Scholar
• Curzon G., O'Reilly S. A coupled iron-caeruloplasmin oxidation system. Biochem. Biophys. Res. Commun. 1960; 2: 284
   Web of Science ®Google Scholar
• Curzon G. Some properties of coupled iron-caeruloplasmin oxidation systems. Biochem. J. 1961; 79: 656
   PubMedGoogle Scholar
• Elvehjem C. A. The biological significance of copper and its relation to iron metabolism. Physiol. Rev. 1935; 15: 471
   Google Scholar
• Lahey M. E., Gubler C. J., Chase M. S., Cartwright G. E., Wintrobe M. M. Studies in copper metabolism. 11. Hematologic manifestations of copper deficiency in swine. Blood 1952; 7: 1053
   PubMed Web of Science ®Google Scholar
• Cartwright G. E., Guhler C. J., Bush J. A., Wintrobe M. M. Studies on copper metabolism. XVII. Further observations on the anemia of copper deficiency in swine. Blood 1956; 2: 143
   Google Scholar
• Lee G. R., Cartwright G. E., Wintrobe M. M. Heme biosynthesis in copper deficient swine. Proc. Soe. Exp. Biol. Med. 1968; 127: 977
   Google Scholar
• Lee G. R., Nacht S., Lukens J. N., Cartwright G. E. Iron metabolism in copper-deficient swine. J. Clin. Invest. 1968; 47: 2058
   PubMed Web of Science ®Google Scholar
• Undritz E. Oral treatment of iron deficiency. Iron Metabolism, F. Gross. Springer-Verlag, Berlin 1964; 406
   Google Scholar
• Bush J. A., Jensen W. N., Athens J. W., Ashenbrucker H., Cartwright G. E., Wintrobe M. M. Studies on copper metabolism. XIX. The kinetics of iron metabolism and erythrocyte life span in copper deficient swine. J. Exp. Med. 1956; 103: 701
   PubMed Web of Science ®Google Scholar
• Ragan H. A., Nacht S., Lee G. R., Bishop C. R., Cartwright G. E. Effect of caeruloplasmin on plasma iron in copper-deficient swine. Am. J. physiol. 1969; 217: 1320
   PubMedGoogle Scholar
• Roeser H. P., Lee G. R., Nacht S., Cartwright G. E. The role of caeruloplasmin in iron metabolism. J. Clin. Invest. 1970; 49: 2408
   PubMed Web of Science ®Google Scholar
• Lee G. R., Roeser H. P., Nacht S., Cartwright G. E. The physiological significance of caeruloplasmin (ferroxidase) in iron metabolism. J. clin. Invest. 1970; 49: 177, (Abstr.)
   Google Scholar
• Williams D. M., Lee G. R., Cartwright G. E. Ferroxidase activity of rat caeruloplasmin. Am. J. Physiol 1974; 227: 1094
   PubMedGoogle Scholar
• Osaki S., Johnson D. A. Mobilization of liver iron by ferroxidase (caeruloplasmin). J. Biol. Chem. 1969; 244: 5757
   PubMed Web of Science ®Google Scholar
• Osaki S., Johnson D. A., Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J. Biol. Chem. 1971; 246: 3018
   PubMed Web of Science ®Google Scholar
• Lee G. R., Nacht S., Christensen D., Hansen S. P., Cartwright G. E. The contribution of citrate to the ferroxidase activity of serum. Proc. Soc. Exp. Biol Med. 1969; 131: 918
   PubMedGoogle Scholar
• Harris D. C., Aisen P. Facilitation of Fe (II) autoxidation, by Fe (III) complexing agents. Biochem. Biophys. Acta 1973; 329: 156
   PubMedGoogle Scholar
• Caspary W. J., Niziak C., Lanzo D. A., Friedman R., Bachur N. R. Bleomycin A2: a ferrous oxidase. Mol. Pharmacol 1979; 16: 256
   PubMed Web of Science ®Google Scholar
• Muller W. E. G., Yamazaki Z., Brester H., Zahn R. K. Action of bleomycin on DNA and RNA. Eur. J. Biochem. 1972; 31: 518
   PubMedGoogle Scholar
• Gutteridge J. M. C. Identification of malondialdehyde as the TBA-reactant formed by bleomycin-iron free radical damage to DNA. FEBS Lett. 1979; 105: 278
   PubMed Web of Science ®Google Scholar
• Topham R. W., Frieden E. Identification and purification of a non-caeruloplasmin ferroxidase of human serum, /. Biol. Chem. 1970; 245: 6698
   Google Scholar
• Topham R. W., Johnson D. A. Kinetic studies of the Fe (II) oxidation with human serum ferroxidase-II. Arch. Biochem. Biophys. 1974; 160: 647
   PubMedGoogle Scholar
• Williams D. M., Christensen D. D., Lee G. R., Cartwright G. E. Serum azide-resistant ferroxidase activity. Biochem. Biophys. Acta 1974; 350: 129
   PubMedGoogle Scholar
• Gutteridge J. M. C., Tickner T. R. The characterization of thiobarbituric acid reactivity in human plasma and urine. Anal. Biochem. 1978; 91: 250
   PubMed Web of Science ®Google Scholar
• Kibrick A. E., Safler L. B., Skupp S. J. Existence of fatty acid peroxides in normal blood and tissues of man and animals. Proc. Soc. Exp. Biol. Med. 1959; 101: 137
   PubMedGoogle Scholar
• Stocks J., Gutteridge J. M. C., Sharp R. J., Dormandy T. L. The inhibition of lipid autoxidation by human serum and its relationship to serum proteins and α-tocopherol. Clin. Sci. Mol. Med. 1974; 47: 223
   PubMedGoogle Scholar
• Sung S. M., Topham R. W. Lipid components of human ferroxidase II. Biochem. Biophys. Res. Commun. 1973; 53: 824
   PubMedGoogle Scholar
• Topham R. W., Sung C. S. M., Morgan F. G., Prince W. D., Jones S. H. Functional significance of the copper and lipid components of human ferroxidase II. Arch. Biochem. Biophys. 1975; 167: 129
   PubMedGoogle Scholar
• Chin J. L., Calisch M. P., Topham R. W. Purification and characterization of the ferroxidase II from rabbit (Oryctolagns Cuniculus) serum. J. Biochem. 1978; 9: 775
   Google Scholar
• Bates G. W., Workman E. F., Schlabach M. R. Does transferrin exhibit ferroxidase activity?. Biochem. Biophys. Res. Commun. 1973; 50: 84
   PubMedGoogle Scholar
• Macara T. G., Hoy T. G., Harrison P. M. The formation of ferritin from apoferritin. Biochem. J. 1972; 126: 151
   PubMed Web of Science ®Google Scholar
• Bryce C. F. A., Crichton R. R. The catalytic activity of horse spleen apoferritin. Biochem. J. 1973; 133: 301
   PubMed Web of Science ®Google Scholar
• Taborsky G. Interaction between phosvitin and iron and its effect on a rearrangement of phosvitin structure. Biochemistry. 1963; 2: 266
   PubMedGoogle Scholar
• Gutteridge J. M. C., Richmond R., Halliwell B. Oxygen free-radicals and lipid peroxidation. Inhibition by the protein caeruloplasmin. FEBS Lett. 1980; 112: 269
   Web of Science ®Google Scholar
• Gutteridge J. M. C. The protective action of superoxide dismutase on metal-ion catalyzed peroxidation of phospholipid. Biochem. Biophys. Res. Commun. 1977; 77: 379
   PubMedGoogle Scholar
• Kumar K. S., Rowse C., Hochstein P. Copper-induced generation of superoxide in human red cell membrane. Biochem. Biophys. Res. Commun. 1978; 83: 587
   PubMed Web of Science ®Google Scholar
• Goldfischer S., Sternlieb I. Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatulenticular degeneration). Am. J. Pathol 1968; 53: 883
   PubMed Web of Science ®Google Scholar
• Walshe J. M. Some observations on the treatment of Wilson's disease with penicillamine. Birth Defects. 1968; 4: 126
   Google Scholar
• Shokeir M. H. K. Is caeruloplasmin a physiological ferroxidase?. Clin. Biochem. 1972; 5: 115
   PubMedGoogle Scholar
• Bates G., Schlaback M. R. The reaction of ferric salts with transferrin. J. Biol Chem. 1973; 248: 3228
   PubMed Web of Science ®Google Scholar
• Frieden E. Caeruloplasmin: a multi-functional metalloprotein of vertebrate plasma. Biological Roles of Copper. Ciba Foundation Symposium, in press
   Google Scholar
• Walass E., Walaas O. Oxidation of reduced phosphopyrimidine nucleotides, p-phenylendiames, catecholamines and serotonin in the presence of caeruloplasmin. Arch. Biochem. Biophys. 1961; 95: 151
   PubMedGoogle Scholar
• Hoffer A. Caeruloplasmin, adrenaline oxidase and schizophrenia. Dis. Nerv. Syst. 1965; 26: 25
   PubMedGoogle Scholar
• Walaas E., Walaas O., Lovstad R. The interactions of caeruloplasmin with catecholamines. Biochemistry of Copper, J. Peisach, P. Aisen, W. E. Blumberg. Academic Press, New York 1966
   Google Scholar
• Chaix P., Chauvet J., Jezequel J. I etude cinetique de l'oxydation de l'adrenaline en solution tampon-phosphate. Biochem. Biophys. Acta 1950; 4: 471
   Google Scholar
• Chaix P., Pallaget C. Caracteres compares de l'oxydation de la noradrenaline et de l'adrenaline evoluant en solution tampon phosphate on bicarbonate. Biochem. Biophys. Acta 1953; 10: 462
   PubMedGoogle Scholar
• Walaas E., Walaas O., Haavaldsen S., Pedersen B. Spectrophotometric and electron spin resonance studies of complexes of catecholamines with Cu (II) ions and the interaction of caeruloplasmin with catecholamines. Arch. Biochem. Biophys. 1963; 100: 97
   PubMedGoogle Scholar
• Lovstad R. A. Activating effect of copper ions on the interaction of caeruloplasmin with catecholamines. Gen. Pharm. 1979; 10: 147
   PubMedGoogle Scholar
• Barras B. C., Coult D. B., Rich P., Tutt K. J. Substrate specificity of caeruloplasmin phenylalkylamine substrates. Biochem. Pharmacol. 1977; 23: 47
   Google Scholar
• Barras B. C., Coult D. B. Interaction of some centrally active drugs with caeruloplasmin. Biochem. Pharmacol. 1972; 21: 677
   PubMedGoogle Scholar
• Barras B. C., Coult D. B. Effects of some centrally acting drugs on caeruloplasmin. Prog. Brain Res. 1972; 36: 97
   PubMedGoogle Scholar
• Lovstad R. A. Interaction of phenothiazine derivatives with human caeruloplasmin. Biochem. Pharmacol. 1974; 23: 1045
   PubMedGoogle Scholar
• Borg D. C., Cotzias E. C. Interaction of trace metals with phenothiazine drug derivative. I. Structural reactivity correlations. Proc. Natl. Acad. Sri. U.S.A. 1962; 48: 617
   PubMedGoogle Scholar
• Borg D. C., Cotzias G. C. Interaction of trace metals with phenothiazine drug derivatives, II, Formation of free radicals. Proc. Natl. Acad. Sci. U.S.A. 1962; 48: 623
   PubMed Web of Science ®Google Scholar
• Piette L. H., Bulow G., Yamazaki I. Electron-paramagnetic-resonance study of the chlorpromazine free radical formed during enzymic oxidation by peroxidase hydrogen peroxide. Biochem. Biophys. Acta. 1964; 88: 120
   PubMedGoogle Scholar
• Cavanaugh D. J. Oxidation of chlorpromazine by peroxidase and catalase. Science 1957; 125: 1040
   PubMed Web of Science ®Google Scholar
• Lovstad R. A. Kinetic studies on the caeruloplasmin-catalyzed oxidation of phenothiazine derivatives. Biochem. Pharmacol 1975; 24: 475
   PubMed Web of Science ®Google Scholar
• Lovstad R. A. Interaction of some neuroleptic and antidepressive agents with human caeruloplasmin. Biochem. Pharmacol. 1976; 25: 1877
   PubMedGoogle Scholar
• Hampton J. K., Rider L. J., Goka T. J., Preslock J. P. The histaminase activity of caeruloplasmin. Proc. Soc. Exp. Biol. Med. 1972; 141: 974
   PubMedGoogle Scholar
• Butler E. J., Curtis M. J. The effect of Escherichia coli endotoxin on plasma histaminase activity in the domestic fowl and the involvement of caeruloplasmin. Res. yet. Sci. 1977; 22: 267
   Google Scholar
• Hinshaw L. B., Jordan M. M., Vick J. A. Mechanism of histamine release in endotoxin shock. Am. J. Physiol. 1961; 200: 987
   PubMedGoogle Scholar
• Vick J. A., Mehlman B., Heiffer M. H. Early histamine release and death due to endotoxin. Proc. Soc. Exp. Biol. Med. 1971; 137: 902
   PubMedGoogle Scholar
• Butler E. J., Curtis M. J., Harry E. G., Deb J. R. Effect of Escherichia coli endotoxins on plasma para-phenylenediamine oxidase (caeruloplasmin) activity in the domestic fowl. J. Comp. Pathol 1972; 82: 299
   PubMed Web of Science ®Google Scholar
• Curtis M. J., Butler E. J. The response of caeruloplasmin to Escherichia coli endotoxins and adrenal hormones in the domestic fowl. Res. Vet. Sci.
   Google Scholar
• Adelstein S. J., Coombs T. L., Vallee B. L. Metalloenzymes and myocardial infarction. I. The relation between serum copper and caeruloplasmin and its catalytic activity. New Eng. J. Med. 1956; 255: 105
   PubMed Web of Science ®Google Scholar
• Cartwright G. E., Markowitz H., Shields G. S., Wintrobe M. M. Studies on copper metabolism. XXIX. A critical analysis of serum copper and caeruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. Am. J. Med. 1960; 28: 555
   PubMed Web of Science ®Google Scholar
• Weissman N., Pileggi V. J. Inorganic ions. Clinical Chemistry Principles and Technics2nd ed., R. J. Henry, D. C. Cannon, J. W. Winkelman. Harper & Row, New York 1974; 695
   Google Scholar
• Kasper C. B., Deutsch H. F. Immunochemical studies of crystalline human caeruloplasmin and derivatives. J. Biol. Chem. 1963; 238: 2343
   PubMedGoogle Scholar
• Matsuda L., Pearson T., Holzman N. A. Determination of apocaeruloplasmin by radioimmunoassay in nutritional copper deficiency ? Menke's kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr. Res. 1974; 8: 821
   PubMed Web of Science ®Google Scholar
• Deutsch H. F. A chromatographic-spectrophotometric method for the determination of caeruloplasmin. Clin. Chim. Acta 1960; 5: 460
   PubMedGoogle Scholar
• Holmberg C. G., Laurell C. B. Investigations in serum copper. III. Caeruloplasmin as an enzyme. Acta Chem. Scand. 1951; 51: 476
   Google Scholar
• Holmberg C. G., Laurell C. B. Oxidase reactions in human plasma caused by caeruloplasmin. Scand. J. Clin. Lab. Invest. 1951; 3: 103
   PubMed Web of Science ®Google Scholar
• Mailer C., Swartz M. H., Konieczny M., Ambegankar S., Moore V. L. Identity of the paramagnetic element found in increased concentrations in plasma of cancer patients and its relationship to other pathological processes. Cancer Res. 1974; 34: 637
   PubMedGoogle Scholar
• Ravin H. A. Rapid test for hepatolenticular degeneration. Lancet 1956; 2: 726
   Google Scholar
• Akerfeldt S. Oxidation of N., N' dimethy-p-phenyl-enediamine by serum from patients with schizophrenia and with mental disease. Science 1957; 125: 117
   PubMed Web of Science ®Google Scholar
• Michaelis L., Schubert M. P., Granick S. The free radicals of the type of Wurster's salts. J. Am. Chem. Soc 1939; 61: 1981
   Google Scholar
• Henry R. J., Chiamori N., Jacobs S. L., Segalove M. Determination of Caeruloplasmin oxidase in serum. Proc. Soc. Exp. Biol. Med. 1960; 104: 620
   Google Scholar
• Ravin H. A. An improved colorimetric enzymatic assay for caeruloplasmin. J. Lab. Clin. Med. 1961; 58: 161
   PubMed Web of Science ®Google Scholar
• Smith B. S., Wright H. Improved manual and automated procedures for estimation of caeruloplasmin oxidase activity. Clin. Chim. Acta 1974; 50: 359
   Google Scholar
• Nanji M. S. The micro determination of the oxidase activity of caeruloplasmin in biological fluids. Fellowship's thesis, Institute of Medical Laboratory Sciences. 1980
   Google Scholar
• Nicolau C., Horer O., Thomas E., Stroescu E., Pascaru I. Free radicals in enzymatic reactions. I. Free radical formation in the caeruloplasmin-p-phenylenediamine system. Rev. Roum. Chim. 1964; 9: 319
   Google Scholar
• Levine W. G., Peisach J. Studies on the substrate, specificity of caeruloplasmin. Biochim. Biophys. Acta 1962; 63: 528
   PubMedGoogle Scholar
• Johnson D. A., Osaki S., Frieden E. A Micromethod for the determination of ferroxidase (caeruloplasmin) in human serum. Clin. Chem. 1967; 13: 142
   PubMed Web of Science ®Google Scholar
• McDermott J. A., Huber C. T., Osaki S., Frieden E. Role of iron in the oxidase activity of caeruloplasmin. Biochim. Biophys. Acta 1968; 151: 541
   PubMedGoogle Scholar
• Owen J. A., Smith H. Detection of caeruloplasmin after zone electrophoresis. Clin. Chim. Acta 1961; 6: 441
   Web of Science ®Google Scholar
• Schosinsky K. H., Lehmann H. P., Beeler M. F. Measurement of caeruloplasmin from its oxidase activity in serum by use of O-dianisidine dihydrochloride. Clin. Chem. 1974; 20: 1556
   PubMed Web of Science ®Google Scholar
• Rice E. W. Standardization of caeruloplasmin. Activity in terms of international enzyme units. Anal. Biochem. 1962; 3: 452
   PubMed Web of Science ®Google Scholar
• Clausen J. Immunochemical techniques for the identification and estimation of macromolecules in laboratory techniques. Biochemistry and Molecular Biology, T. S. Work, E. Work. North-Holland, Amsterdam 1972
   Google Scholar
• Lovstad R. A. A comparative study of the two different activities of caeruloplasmin in human sera. Eur. J. Biochem. 1969; 8: 303
   PubMedGoogle Scholar
• Pettersson G. A model for the caeruloplasmin catalyzed oxidation of dimethyl-p-phenylenediamine. Ada Chem. Scand. 1969; 23: 2317
   PubMedGoogle Scholar
• Walaas E., Walaas O. Oxidation of reduced phosphopyridine nucleotides by p-phenylenedi-amines, catecholamines and serotonin in the presence of caeruloplasmin. Arch. Biochem. Biophys. 1961; 95: 151
   PubMedGoogle Scholar
• Peisach J., Levine W. G. On the mechanism of caeruloplasmin-catalyzed oxidations. Biochim. Biophys. Acta. 1963; 77: 615
   Google Scholar
• Thompson R. H. S., Watson D. Serum copper levels in pregnancy and pre-enclampsia. J. Clin. Pathol. 1949; 2: 193
   Google Scholar
• Lahey M. E., Gubler C. G., Cartwright G. E., Wintrobe M. M. Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states. J. Clin. Invest. 1953; 32: 329
   PubMed Web of Science ®Google Scholar
• Scheinberg I. H., Cook C. D., Murphy J. A. The concentration of copper and caeruloplasmin in maternal and infant plasma at delivery. J. Clin. Invest. 1954; 33: 963
   Web of Science ®Google Scholar
• O'Leary J. A., Spellacy W. N. Zinc and copper levels in pregnant women and those taking oral contraceptives. Am. J. Obstet. Gynecol. 1969; 103: 131
   PubMedGoogle Scholar
• Burrows S., Pekala B. Serum copper and caeruloplasmin in pregnancy. Am. J. Obstet. Gynecol. 1971; 109: 907
   PubMedGoogle Scholar
• Carruthers M. E., Hobbs C. B., Warren R. L. Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives. J. Clin. Pathol. 1966; 19: 498
   PubMed Web of Science ®Google Scholar
• O'Leary J. A., Feldman M. A. S. Serum copper levels in normal subjects receiving an oral contraceptive. J. Reprod. Med. 1968; 2: 185
   Google Scholar
• Mendenhall H. W. Effect of oral contraceptives on serum protein concentrations. Am. J. Obstet. Gynecol. 1970; 106: 750
   PubMedGoogle Scholar
• Briggs M., Austin J., Sianiford M. Oral contraceptives and copper metabolism. Nature (London). 1970; 225: 81
   PubMedGoogle Scholar
• Briggs M., Briggs M. Effects of some contraceptive steroids on serum protein changes of women. Biochem. Pharmacol. 1973; 22: 2277
   PubMed Web of Science ®Google Scholar
• Russ E. M., Raymunt J., Pillar S. Effect of oestrogen therapy in caeruloplasmin concentration in a man with Wilson's disease. J. Clin. Endocrinol. 1957; 17: 908
   Google Scholar
• Evans G. W., Cornatzer N. F., Cornatzer W. E. Mechanisms for hormone-induced alterations in serum caeruloplasmin. Am. J. Physiol. 1970; 218: 613
   PubMedGoogle Scholar
• Jackson R. L., Chan L., Snow L. D., Means A. R. Hormonal regulation of lipoprotein synthesis. Disturbances in Lipid and Lipoprotein Metabolism, J. M. Dietschy, A. M. Gotto, J. A. Ontko. American Physiological Society, Bethesda, Md. 1978; 139
   Google Scholar
• Russ E. M., Raymunt J. Influence of estrogens on total serum copper and caeruloplasmin. Proc. Soc. Exp. Biol. 1956; 92: 465
   PubMedGoogle Scholar
• Cox W. D. Factors influencing serum caeruloplasmin levels in normal individuals. J. Lab. Clin. Med. 1966; 68: 893
   PubMedGoogle Scholar
• Sass-Kortsak A., Beam A. G. Hereditary disorders of copper metabolism. The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngarden, D. S. Fredrickson. McGraw-Hill, New York 1978; 1098
   Google Scholar
• Cartwright G. E., Wintrobe M. M. Copper metabolism in normal subjects. Am. J. Clin. Nut. 1964; 14: 224
   PubMed Web of Science ®Google Scholar
• Hilderbrand D. C., Fahim Z., James E., Fahim M. Caeruloplasmin and alkaline phosphatase levels in cord serum of term preterm and physiologically jaundiced neonates. Am. J. Obstet. Gynecol. 1974; 118: 950
   PubMedGoogle Scholar
• Scheinberg I. H., Sternlieb I. Copper metabolism. Pharmacol. Rev. 1960; 12: 355
   PubMed Web of Science ®Google Scholar
• Rice E. W. Correlation between serum copper, caeruloplasmin activity and C-reactive protein. Clin. Chim. Acta 1960; 5: 632
   PubMedGoogle Scholar
• Johnson N. C., Kheim J., Kountz W. B. Influence of sex hormones on total serum copper. Proc. Soc. Exp. Biol. 1959; 102: 98
   PubMedGoogle Scholar
• Werner W. Serum protein changes during the acute phase reaction. Clin. Chim. Acta 1969; 25: 299
   PubMed Web of Science ®Google Scholar
• Gordon A. H. The effects of trauma and partial hepatectomy on the rates of synthesis of plasma proteins by the liver. Plasma Protein Metabolism; Regulation of Synthesis, Distribution, and Degeneration, M. A. Rothschild, T. Waldmann. Academic Press, New York 1970; 351
   Google Scholar
• Starcher B., Hill C. H. Isolation and characterization of induced caeruloplasmin from chicken serum. Biochim, Biophys. Acta. 1966; 127: 400
   PubMedGoogle Scholar
• Piercy D. W. T., Bingley J. B. Afebrile augmentation of fibrinogen and caeruloplasmin synthesis and neutrocytosis induced by mycoplasma mycoides var. mycoides in the rabbit. J. Comp. Pathol. 1975; 85: 213
   PubMedGoogle Scholar
• Kampschmidt R. F., Schultz G. A. Hypoferremia in rats following injection of bacterial endotoxin. Proc. Soc. Exp. Biol. Med. 1961; 106: 870
   PubMedGoogle Scholar
• Baker J. P., Wilson J. B. Hypoferremia in mice and its application to the bioassay of endotoxin. J. Baa. 1965; 90: 903
   Google Scholar
• Leong D., Diaz R., Milner K., Rudbach J. A., Wilson J. B. Some structural and biological properties of Brucella endotoxin. Infect. Immunol. 1970; 1: 174
   PubMedGoogle Scholar
• Janoff A., Zweifach B. W. Inactivation of bacterial endotoxins and endotoxin by iron. J. Exp. Med. 1960; 112: 23
   PubMedGoogle Scholar
• Weinberg E. D. Role of iron in host parasite interactions. J. Infect. Dis. 1971; 124: 401
   PubMed Web of Science ®Google Scholar
• Piercy D. W. T. Acute phase responses to experimental salmonellosis in calves and colibacillosis in chickens, serum iron and caeruloplasmin. J. Comp. Pathol. 1979; 89: 309
   PubMed Web of Science ®Google Scholar
• Anon. Iron and resistance to infection. Lancet 1974; 2: 325
   PubMedGoogle Scholar
• Sussman M. Iron and infection. Iron in Biochemistry and Medicine, A. Jacobs, M. Worwood. Academic Press, London 1974; 650
   Google Scholar
• Bullen J. J., Rogers H. J., Griffiths E. Bacterial iron metabolism in infection and immunity. Microbial Iron Metabolism, J. B. Neilands. Academic Press, New York 1974
   Google Scholar
• Rogers H. J., Synge C., Kimber B., Bayley P. M. Production of enterochelin by Escherichia coli 0111. Biochim, Biophys. Acta 1977; 497: 548
   PubMedGoogle Scholar
• Bullen J. J., Leigh L. C., Rogers H. J. The effect of iron compounds on the virulence of Escherichia coli from guinea pigs. Immunology 1968; 15: 581
   PubMed Web of Science ®Google Scholar
• Bullen J. J., Rogers H. J. Bacterial iron metabolism and immunity to Pasteurella septica and Escherichia coli. Nature (London) 1969; 224: 380
   PubMed Web of Science ®Google Scholar
• Rogers H. J. Iron-binding catechols and virulence in Escherichia coli. Infect. Immunol. 1973; 7: 445
   PubMed Web of Science ®Google Scholar
• Badley S. G. Cellular and molecular mechanisms of action of baterial endotoxins. Ann. Rev. Microbiol. 1979; 33: 67
   PubMedGoogle Scholar
• Frank L., Yam J., Roberts R. J. The role of endotoxin in protection of adult rats from oxygen-induced lung toxicity. J. Clin. Invest. 1978; 61: 269
   PubMed Web of Science ®Google Scholar
• Swartz H. M., Weisner J. Radiation effects on plasma electron spin resonance spectra of cancer patients. Radiology 1972; 104: 209
   PubMedGoogle Scholar
• Horn R. A., Friesen E. J., Stephens R. L., Hedrick W. R., Zimbrick J. D. Electron spin resonance studies on properties of caeruloplasmin and transferrin in blood from normal human subjects and cancer patients. Cancer 1979; 43: 2392
   PubMedGoogle Scholar
• Foster M. A., Pocklington T., Miller J. D. B., Mallard J. R. A study of electron spin resonance spectra of whole blood from normal and tumour bearing patients. Br. J. Cancer 1973; 28: 340
   PubMedGoogle Scholar
• Ungar-Waron H., Gluckman A., Spira E., Waron M., Trainin Z. Caeruloplasmin as a marker of neoplastic activity in rabbits bearing the VX-2 carcinoma. Cancer Res. 1978; 38: 1296
   PubMed Web of Science ®Google Scholar
• Voelkel E. F., Levine L., Alper C. E., Tashjian A. H. Acute phase reactants caeruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VX2 carcinoma. J. Exp. Med. 1978; 147: 1078
   PubMed Web of Science ®Google Scholar
• Kuehl F. A., Jr., Humes J. L., Egan R. W., Ham E. A., Beverdige G. C., Van Arman C. G. Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature 1977; 265: 170
   PubMed Web of Science ®Google Scholar
• Fisher G. L., Shifrine M. Hypothesis for the mechanism of elevated serum copper in cancer patients. Oncology 1978; 35: 22
   PubMedGoogle Scholar
• Hunt A. H., Parr R. M., Taylor D. M., Trott N. E. Relation between cirrhosis and trace metal content of liver with special reference to primary biliary cirrhosis and copper. Br. Med. J. 1963; 2: 1498
   PubMedGoogle Scholar
• Worwood M., Taylor D. M., Hunt A. H. Copper and manganese concentrations in biliary cirrhosis of the liver. Br. Med. J. 1968; 3: 344
   PubMedGoogle Scholar
• Fleming C. R., Dickenson E. R., Baggenstoss A. H., McCall J. J. Copper and primary biliary cirrhosis. Gastroenterology 1974; 67: 1182
   PubMed Web of Science ®Google Scholar
• Deering T. B., Dickson E. R., Fleming C. R., Geall M. G., McCall J. T., Baggenstoss A. H. Effect of D-penicillamine on copper retention in patients with primary biliary cirrhosis. Gastroenterology 1977; 72: 1208
   PubMed Web of Science ®Google Scholar
• Ritland S., Stennes E., Skrede S. Hepatic copper content, urinary copper excretion and serum caeruloplasmin in liver disease. Scand. J. Gastroenterol. 1977; 12: 81
   PubMed Web of Science ®Google Scholar
• La Russo N. F., Williams H. H., Summerskill M. D., McCall J. T. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology 1976; 70: 653
   PubMedGoogle Scholar
• Perman J. A., Werlin S. L., Grand R. J., Watkins J. B. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson's disease in children. J. Pediatr. 1979; 94: 564
   PubMed Web of Science ®Google Scholar
• Ropes M. W., Perlman G. E., Kaufman D. E., Bauer W. Electrophoretic distribution of proteins in plasma in rheumatoid arthritis. J. Clin. Invest. 1954; 33: 311
   PubMed Web of Science ®Google Scholar
• Evers A. Das Verhalten des serum kupfers bei primar chronischer polyarthritis. Z. Rheumaforsch. 1952; 11: 164
   PubMedGoogle Scholar
• Plantin L. U., Strandberg P. O. Whole-blood concentrations of copper and zinc in rheumatoid arthritis studied by activation analysis. Acta Rheum. Scand. 1965; IT: 30
   Google Scholar
• Bajpayee D. P. Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis. Ann. Rheum. Dis. 1975; 34: 162
   PubMedGoogle Scholar
• Scudder P. R., Al-Timimi W., McMurray W., White A. G., Zoob B. C., Dormandy T. L. Serum copper and related variables in rheumatoid arthritis. Ann. Rheum. Dis. 1978; 37: 67
   PubMed Web of Science ®Google Scholar
• Brown D. H., Buchanan W. W., EI-Ghobarey A. F., Smith A. E., Teape J. Serum copper and its relationship to clinical symptoms in rheumatoid arthritis. Ann Rheum. Dis. 1979; 38: 174
   PubMed Web of Science ®Google Scholar
• Lorber A., Cutler L. S., Chang C. C. Serum copper levels in rheumatoid arthritis: relationship of elevated copper to protein alterations. Arthritis Rheum. 1968; II: 65
   Google Scholar
• Sternlieb I., Sandson J. I., Morell A. G., Korotkin E., Scheinberg I. H. Noncaeruloplasmin copper in rheumatoid arthritis. Arthritis Rheum. 1969; 12: 458
   PubMedGoogle Scholar
• McMurray W., Martin V. M., Scudder P., Stocks J., White A. G., Dormandy T. L. Urinary copper excretion in rheumatoid arthritis. Ann. Rheum. Dis. 1975; 34: 340
   PubMedGoogle Scholar
• Niedermeier W. Concentration and chemical state of copper in synovial fluid and blood serum of patients with rheumatoid arthritis. Ann. Rheum. Dis. 1965; 24: 544
   PubMed Web of Science ®Google Scholar
• Kushner I., Somerviile J. A. Permeability of human synovial membrane to plasma proteins. Arthritis Rheum. 1971; 14: 560
   PubMed Web of Science ®Google Scholar
• Babior B. M. Oxygen-dependent microbial killing by phagocytes. New Engl. J. Med., 298: 659
   PubMedGoogle Scholar
• Babior B. M., Kipnes R. S., Curnutte J. T. The production by leucocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 1973; 52: 741
   PubMed Web of Science ®Google Scholar
• McCord J. M. Free radicals and inflammation protection of synovial fluid by superoxide dismutase. Science 1974; 185: 529
   PubMed Web of Science ®Google Scholar
• Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. FEBS Lett. 1978; 96: 238
   PubMed Web of Science ®Google Scholar
• Denko C. W. Protective role of caeruloplasmin in inflammation. Agents and Actions 1979; 9: 333
   PubMedGoogle Scholar
• Menkes J. J., Alter M., Steigleder G. K., Weakly D. R., Sung J. H. A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration. Pediatrics 1962; 29: 764
   PubMed Web of Science ®Google Scholar
• Danks D. M. Copper transport and utilization in Menke's syndrome and in mottled mice. Inorg. Perspect. Biol. Med. 1977; 1: 73
   Web of Science ®Google Scholar
• Holtzman N. A. Menke's kinky hair syndrome: a genetic disease involving copper. Fed. Proc. 1976; 35: 2276
   PubMedGoogle Scholar
• Danks D. M., Campbell P. E., Walker-Smith J., Stevens J. M., Gillespie J. M., Blomfield J. Menke's kinky hair syndrome. Lancet 1972; 1: 1100
   PubMed Web of Science ®Google Scholar
• Danks D. M., Campbell P. E., Stevens B. J., Mayne V., Cartwright E. An inherited defect in copper absorption with wide-spread effects. Pediatrics 1972; 50: 188
   PubMed Web of Science ®Google Scholar
• Hunt D. M. Primary defect in copper transport underlies mottled mutants in the mouse. Nature (London), 249: 852
   PubMedGoogle Scholar
• French J. H., Sherard E. S., Lubell H., Brotz M., Moore C. L. Trichopoliodystrophy. I. Report of a case and biochemical studies. Arch. Neurol. 1972; 26: 229
   PubMedGoogle Scholar
• Bucknall W. E., Haslam R. H. A., Holtzman N. A. Kinky hair syndrome. Response to copper therapy. Pediatrics 1973; 52: 653
   PubMedGoogle Scholar
• Goka T. J., Stevenson R. E., Hefferan P. M., Howell R. R. Menkes disease: a biochemical abnormality in cultured human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 604
   PubMed Web of Science ®Google Scholar
• Portia E., Hunt D. M. A study of the copper-binding proteins in liver and kidney tissue of neonatal normal and mottled mice. Biochem. J. 1979; 183: 721
   PubMedGoogle Scholar
• Coleman S. L., Sanders T. E., Field B. D. Hepatolenticular degeneration: a case report including spectroanalytic studies. Am. J. Ophthalmol. 1963; 56: 297
   PubMedGoogle Scholar
• Sterlieb I., Morell A. G., Scheinberg I. H. Homozygosity and heterozygosity in Wilson's disease. Wilson's Disease: Some Current Concepts, J. M. Walshe, J. N. Cummings. Blackwell, Oxford 1961; 133
   Google Scholar
• Scheinberg J. H., Sternleib I. Wilson's disease. Ann. Rev. Med 1965; 16: 119
   PubMedGoogle Scholar
• Walshe J. M. Wilson's disease, a review. The Biochemistry of Copper, J. Peisach, P. Aisen, W. E. Blumberg. Academic Press, New York 1966
   Google Scholar
• Walshe J. M. The physiology of copper in man and its relation to Wilson's disease. Brain 1967; 90: 149
   PubMed Web of Science ®Google Scholar
• Walshe J. M. Wilson's disease: its diagnosis and management. Br. J. Hosp. Med. 1970; 41: 91
   Google Scholar
• Goldstein N. P., Owen C. A. Introduction: symposium on copper metabolism and Wilson's disease. Mayo Clin. Proc 1974; 49: 363
   PubMedGoogle Scholar
• Wilson S. A. K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912; 34: 295
   Google Scholar
• Rampel A. Über das Wesen und die bedeutung der leberveränderungen und der Pigmentierungen bei den damit verbundenen Fällen von Pseudosklerose zugleich ein Beitrag zur hehre von der Pseudo-sklerose (Westzphal —Strümpell). Dtsch. Z. Nervenh. 1913; 49: 54
   Google Scholar
• Ghazebrook A. J. Wilson's disease. Edinburgh Med. J. 1945; 52: 83
   Google Scholar
• Cummings J. N. The copper and iron content of the brain and liver in normal and in hepatolenticular degeneration. Brain 1948; 71: 410
   PubMed Web of Science ®Google Scholar
• Owen C. A. Similarity of chronic copper toxicity in rats to copper deposition of Wilson's disease. Mayo Clin. Proc 1974; 49: 368
   PubMed Web of Science ®Google Scholar
• Beam A. G. A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration). Ann. Hum. Genet. 1960; 24: 33
   PubMedGoogle Scholar
• Beam A. G. Genetic and biochemical aspects of Wilson's disease. Am. J. Med. 1953; 15: 442
   PubMedGoogle Scholar
• Arima M., Sano I. Genetic studies of Wilson's disease in Japan. Birth Defects 1968; 4: 54
   Google Scholar
• Coc W. D., Fraser F. C., Sass-Kortsakia A. A. Genetic study of Wilson's disease—evidence for heterogeneity. Am. J. Hum. Genet. 1972; 24: 646
   PubMedGoogle Scholar
• Scheinberg I. H., Gitlin D. Deficiency of caeruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952; 116: 484
   PubMed Web of Science ®Google Scholar
• Bearn A. G., Kunkel H. G. Biochemical abnormalities in Wilson's disease. J. Clin. Invest. 1952; 31: 616
   Google Scholar
• Sass-Kortsak A., Cherniak M., Geiger D. W., Slater R. J. Observations on caeruloplasmin in Wilson's disease. J. Clin. Invest. 1959; 38: 1672
   PubMedGoogle Scholar
• Sternleib I., Scheinberg I. H. The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterology. 1979; 77: 138
   PubMedGoogle Scholar
• Sass-Kortsak A. Hepatolenticular (Kinnear Wilson's disease). Handbuch der Inneren Medizin5th ed., H. Schwiegk. Springer, Berlin 1974; Vol. 7: 627
   Google Scholar
• Beam A. G., Kunkel H. G. Localization of Cu64 in serum fractions following oral administration: an alteration in Wilson's disease. Proc. Soc. Exp. Biol. Med. 1954; 85: 44
   PubMed Web of Science ®Google Scholar
• McLntyre N., Clink H. M., Leri A. J., Cumings J. N., Sherlock S. Haemolytic anaemia in Wilson's disease. New Engl. J. Med. 1967; 276: 439
   PubMedGoogle Scholar
• Deiss A., Lee G. R., Cartwright G. E. Haemolytic anaemia in Wilson's disease. Ann. Int. Med. 1970; 73: 413
   PubMed Web of Science ®Google Scholar
• Iser J. H., Stevens B. J., Stening G. F., Hurley M. D., Smallwood R. A. Haemolytic anaemia of Wilson's disease. Gastroenterology 1974; 67: 290
   PubMedGoogle Scholar
• Cartwright G. E., Hodges R. E., Gubler C. J., Mahoney J. P., Daum K., Wintrobe M. M., Bean W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J. Clin. Invest. 1954; 33: 1487
   PubMedGoogle Scholar
• Tu J. B., Blackwell R. Q., Fresh J. W., Watten R. H. Diagnosis and treatment studies of patients with Wilson's disease. Birth Defects 1968; 4: 114
   Google Scholar
• Rosenoer V. M., Franglen G. Caeruloplasmin in Wilson's disease. Lancet 1959; 2: 1163
   PubMedGoogle Scholar
• Sternleib I., Scheinberg I. H. Prevention of Wilson's disease in asymptomatic patients. N. Engl. J. Med. 1968; 278: 352
   PubMedGoogle Scholar
• German J. L., Bearn A. G. Effect of oestrogens on copper metabolism in Wilson's disease. J. Clin. Invest. 1961; 40: 445
   PubMedGoogle Scholar
• Scheinberg I. H., Sternlieb I. Environmental treatment of a hereditary illness: Wilson's disease. Ann. Intern. Med. 1960; 53: 1151
   PubMedGoogle Scholar
• La Russo N. F., Summerskill W. H. S., McCall J. T. Abnormalities of chemical tests for copper in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology 1976; 70: 653
   PubMedGoogle Scholar
• Neifakh S. A., Vasiletz I. M., Shavlosky M. M. Molecular pathology of caeruloplasmin. Biochem. Genetics 1972; 6: 231
   PubMedGoogle Scholar
• Needleman S. B., Sahgal V., Boshes B. Studies on the biochemical characterization of human caeruloplasmin. Experientia 1970; 26: 495
   PubMedGoogle Scholar
• Holtzman N. A., Gaumnitz B. M. Studies on the rate of release and turnover of caeruloplasmin and apoceruloplasmin in rat plasma. J. Biol. Chem. 1970; 245: 2354
   PubMed Web of Science ®Google Scholar
• Walshe J. M. Studies on the oxidase property of caeruloplasmin. Factors in normal and Wilson's disease serum affecting oxidase activity. J. Clin. Invest. 1963; 42: 1048
   PubMedGoogle Scholar
• Gollan J. L., Stocks J., Dormandy T. L., Sherlock S. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease. J. Clin. Pathol. 1977; 30: 81
   PubMedGoogle Scholar
• Bush J. A., Mahoney J. P., Markowitz H., Gubler G. J., Cartwright G. E., Wintrobe M. M. Studies on copper metabolism. XVI. Radioactive copper studies in patients with hepatolenticular degeneration. J. Clin. Invest. 1955; 34
   Google Scholar
• Jenson W. N., Kamin H. Copper transport and excretion in normal subjects and in patients with Laennec's cirrhosis and Wilson's disease. A study with Cu64. J Lab. Clin. Med. 1957; 49: 200
   PubMedGoogle Scholar
• Strickland G. T., Beckner W. M., Leu M. L. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls. Clin. Sci. 1972; 43: 617
   PubMed Web of Science ®Google Scholar
• Newlon-Tauxe W., Goldstein N. P., Randall R. V., Gross J. B. Copper metabolism in carriers of Wilson's disease: analysis of kinetics of intravenously infected radiocopper as a means of detecting the carrier state. Birth Defects 1968; 4: 60
   Google Scholar
• Osborn S. B., Walshe J. M. Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport. Clin. Sci. 1965; 29: 575
   PubMedGoogle Scholar
• Smallwood R. A., McLlveen B., Rosenoer V. M., Sherlock S. Copper kinetics in Liver disease. Gut. 1971; 12: 139
   PubMed Web of Science ®Google Scholar
• Osborn S. B., Walsh J. M. Copper uptake by the liver; study of a Wilson's disease family. Wilson's Disease: Some Current Concepts, J. M. Walshe, J. N. Cummings. Blackwell, Oxford 1961; 141
   Google Scholar
• Osborn S. B., Roberts C. N., Walshe J. M. Uptake of radiocopper by the liver. A study of patients with Wilson's disease and various control groups. Clin. Sci. 1963; 24: 13
   PubMedGoogle Scholar
• Scheinberg I. H., Harris R. S., Morell A. G., Dubin D. Some aspects of the relation of caeruloplasmin to Wilson's disease. Neurology 1958; 8(Suppl. 1)44
   PubMedGoogle Scholar
• Carrico R. J., Deutsch H. F. Some properties of caeruloplasmin from patients with Wilson's disease. Biochem. Med 1969; 3: 117
   Google Scholar
• Sternlieb I., Morell A. G., Tucher W. D., Green M. W., Scheinberg I. H. The incorporation of copper into caeruloplasmin in vivo. Studies with copper64 and copper67. J. Clin. Invest. 1961; 40: 1834
   PubMedGoogle Scholar
• Sternlieb I., Morell A. G., Bauer C. D., Combes B., Sternberg S. D. B., Scheinberg I. H. Detection of the heterozygous carrier of the Wilson's disease gene. J. Clin. Invest. 1961; 40: 707
   PubMedGoogle Scholar
• Gibbs K., Walshe J. M. Studies with radioactive copper (64Cu and 67Cu); the incorporation of radioactive copper into caeruloplasmin in Wilson's disease and in primary biliary cirrhosis. Clin. Sci. 1979; 41: 189
   Google Scholar
• Verling J. M., Shrager R., Rumble W. F., Aamodt R., Berman M. D., Jones E. A. Incorporation of radiocopper into caeruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease. Gastroenterology 1978; 74: 652
   PubMedGoogle Scholar
• Strickland G. T., Blackwell R., Watten R. H. Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance. Am. J. Med. 1971; 51: 31
   PubMedGoogle Scholar
• Frommer D. J. Defective biliary excretion of copper in Wilson's disease. Gut 1974; 15: 125
   PubMed Web of Science ®Google Scholar
• Scheinberg I. H., Sternleib I. Wilson's Disease. Ann. Rev. Med. 1965; 16: 119
   PubMedGoogle Scholar
• Willvonseder R., Goldstein N. P., Newlon-Tauxe W. Long-term retention of radiocopper (67Cu) and the diagnosis of Wilson's disease. Mayo Clin. Proc 1974; 49: 387
   PubMedGoogle Scholar
• Uzman L. L., Iber F. L., Chalmers T. C., Knowlton M. The mechanism of copper deposition in the liver in hepatolenticular degeneration. Am. J. Med. Sci. 1956; 231: 511
   PubMedGoogle Scholar
• Sternlieb I. Diagnosis of Wilson's disease. Gastroenterology 1978; 74: 787
   PubMed Web of Science ®Google Scholar
• Gibbs K., Walshe J. M. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q. J. Med 1979; 48: 447
   PubMedGoogle Scholar
• Enger E. Wilson's disease: report of a case with normal serum caeruloplasmin. Acta Med. Scand. 1959; 163: 121
   PubMedGoogle Scholar
• Walshe J. M., Briggs J. Caeruloplasmin in liver disease, a diagnostic pitfall. Lancet 1962; 2: 263
   PubMed Web of Science ®Google Scholar
• Bucholz C. F. Khemische untersuchung der vanillenschoten (siliqua-vaniilae). Rep. Pharm. 1816; 2: 253
   Google Scholar
• Kolthoff I. M., Willeford B. R. A stable equimolar copper (II) ? albumin complex. J. Am. Chem. Soc 1957; 79: 2656
   Google Scholar
• Peters T. Interaction of one mole of copper with the alpha amino group of bovine serum albumin. Biophys. Acta 1960; 39: 546
   PubMedGoogle Scholar
• Peters T., Blumenstock F. A. Copper-binding properties of bovine serum albumin and its amino-terminal peptide fragment. J. Biol. Chem. 1967; 242: 1574
   PubMed Web of Science ®Google Scholar
• Neifakh S. A., Monakhov N. K., Shaposhnikov A. M., Zubzhitski Y. N. Localization of caeruloplasmin biosynthesis in human and monkey liver cells and its copper regulation. Experientia 1969; 25: 337
   PubMedGoogle Scholar
• Holtzman N. A., Graumnitz B. M. Identification of an apocaeruloplasmin-like substance in the plasma of copper-deficient rats. J. Biol. Chem. 1970; 245: 2350
   PubMedGoogle Scholar
• Underwood E. J. Copper in trace elements. Hum. Anim. Nutr.3rd ed. Academic Press, New York 1971; 57
   Google Scholar
• Evans G. W. Copper homeostasis in the mammalian system. Physiol. Rev. 1973; 53: 535
   PubMed Web of Science ®Google Scholar
• VanCampen D. R. Absorption of copper from the gastrointestinal tract. Intestinal Absorption of Metal Ions, Trace Elements and Radionuclides, S. C. Skoryna, D. Waldron-Edward. Oxford, Pergamon 1971; 211
   Google Scholar
• Mills C. F. Trace element deficiency and excess in animals. Chem. Br. 1979; 15: 512
   Google Scholar
• Owen C. A., Jr. Uptake of 67Cu by caeruloplasmin in vitro. Proc. Soc. Exp. Biol. Med. 1975; 149: 681
   PubMedGoogle Scholar
• Broman L. The function of caeruloplasmin—a moot question. Molecular Basis of Some Aspects of Mental Activity, O. Walaas. Academic Press, London 1976; 131
   Google Scholar
• Owen C. A., Jr. Metabolism of radiocopper (Cu64) in the rat. Am. J. Pkysiol. 1965; 209: 900
   PubMed Web of Science ®Google Scholar
• Marceau N., Aspin N. Distribution of caeruloplasmin-bound 67Cu in the rat. Am. J. PhysioL 1972; 222: 106
   PubMed Web of Science ®Google Scholar
• Marceau N., Aspin N. The intracellular distribution of the rradiocopper derived from caeruloplasmin and from albumin. Biochim, Biophys. Acta 1973; 293: 338
   Google Scholar
• Marceau N., Aspin N. The association of the copper derived from caemloplasmin with cytocuprein. Biophys. Acta 1973; 328: 351
   PubMed Web of Science ®Google Scholar
• Hsieh H. S., Frieden E. Evidence for caeruloplasmin as a copper transport protein. Biochim, Biochem. Res. Commun. 1975; 67: 1326
   PubMed Web of Science ®Google Scholar
• Linder M. C., Moor J. R. Plasma caeruloplasmin. Evidence for its presence in and uptake by heart and other organs of the rat. Biochim. Biophys. Acta 1977; 499: 329
   PubMed Web of Science ®Google Scholar
• Williams R. J. P., DaSilva J. U. R. R. F. High redox potential chemicals in biological systems. New Trends in Bio-inorganic Chemistry, R. J. P. Williams, J. R. R. F. DaSilva. Academic Press, New York 1978; 170
   Google Scholar
• Pryor W. A. Free radical reactions and their importance in biochemical systems. Fed. Proc. 1973; 32: 1862
   PubMedGoogle Scholar
• Pryor W. A., Stanley J. P., Blair E. Autoxidation of polyunsaturated fatty acids. II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endo-peroxides. Lipids 1976; 2: 370
   Google Scholar
• Pryor W. A. The role of free radical reactions in biological systems, chap. 1. Free Radicals in Biology, W. A. Pryor. Academic Press, New York 1976; Vol. 1
   Google Scholar
• Gutteridge J. M. C. Consequences of lipid autoxidation in biological material. Ph.D. thesis, London University. 1974
   Google Scholar
• Machlin L. J., Gordon R. S., Meisky K. H. The effect of antioxidants on vitamin E deficiency symptoms and production of liver peroxide in the chicken. J. Sutr. 1959; 67: 333
   Google Scholar
• Tappel A. L. Studies of the mechanism of vitamin E action. II. Inhibition of unsaturated fatty acid oxidation catalyzed by hematin compounds. Arch, Biochem. Biophys. 1954; 50: 473
   PubMed Web of Science ®Google Scholar
• Tappel A. L., Zalkin H. Lipid peroxidation in isolated mitochondria. Arch. Biochem. Biophys. 1959; 80: 326
   Google Scholar
• Pollard C. J., Biem J. G. Studies on the biological function of vitamin E. II. The nature of the specific activating effect of tocopherol in aged preparations of cytochrome reductases. J. Biol. Chem. 1960; 235: 1178
   PubMedGoogle Scholar
• Vidláková M., Erażimova J., Horky J., Placer Z. Relationship of serum antioxidative activity to tocopherol and serum inhibitor of Lipid Peroxidation. Clin. Chem. Acta 1972; 36: 61
   PubMedGoogle Scholar
• Gutteridge J. M. C. The membrane effects of vitamin E., cholesterol and their acetates on peroxidative susceptibility. Res. Commun. Chem. Path. Pharm. 1978; 22: 563
   PubMedGoogle Scholar
• Hirsch H. M. Tissue autoxidation inhibitors. I. The inhibition of DOPA autoxidation by extracts from normal and neoplastic tissues. Cancer Res. 1955; 15: 249
   PubMedGoogle Scholar
• Barber A. A., Wilbur K. M. The effect of X-irradiation on the antioxidant activity of mammalian tissues. Radiat. Res. 1959; 10: 167
   PubMedGoogle Scholar
• Barber A. A. Inhibition of lipid peroxide formation by vertebrate blood serum. Arch. Biochem. Biophys. 1961; 92: 38
   PubMedGoogle Scholar
• Wills E. D. Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acids. Biochim. Biophys. Acta 1965; 98: 238
   PubMed Web of Science ®Google Scholar
• Placer Z., Slabochova Z. Inhibition of the lipoxidase system by serum proteins. Biochim. Biophys. Acta 1961; 48: 427
   PubMedGoogle Scholar
• Placer Z., Slabocheva Z., Veselkova A. Der Biologische Einfluss der. Antioxydantein, Nahrung 1964; 8: 333
   Google Scholar
• Stocks J., Gutteridge J. M. C., Dormandy T. L. The inhibition of lipid autoxidation by human serum proteins. Symp. on Metal Catalyzed Lipid Oxidation. St. Bartholomew's Hospital, London 1975
   Google Scholar
• Al-Timmimi D., Dormandy T. L. The inhibition of lipid autoxidation by human caeruloplasmin. Biochem. J. 1977; 168: 283
   PubMedGoogle Scholar
• Stocks J., Gutteridge J. M. C., Sharp R. J., Dormandy T. L. Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin. Sci. Mol. Med. 1974; 47: 215
   PubMedGoogle Scholar
• Stocks J. Studies on the antioxidant components of serum and red blood cells. Ph.D., thesis, London University, submitted
   Google Scholar
• Abrams B. C., Gutteridge J. M. C., Stocks J., Friedman M., Dormandy T. L. Vitamin, E in neonatal hyperbilirubinaemia. Arch. Dis. Child. 1973; 48: 721
   PubMedGoogle Scholar
• Goldstein I. M., Kaplan H. B., Edelson H. S., Weissman G. Caeruloplasmin: a scavenger of superoxide anion radicals. J. Biol. Chem. 1979; 254: 4040
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M. C., Richmond R., Halliwell B. Inhibition of the iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferoxamine. Biochem. J. 1979; 184: 469
   PubMed Web of Science ®Google Scholar
• McClune G. J., Fee J. A. Stopped flow. Spectrophotometric observation of superoxide dismutation in aqueous solution. FEBS Lea. 1976; 67: 294
   PubMed Web of Science ®Google Scholar
• Halliwell B. An attempt to demonstrate a reaction between superoxide and hydrogen peroxide. FEBS Leu. 1976; 72: 8
   PubMed Web of Science ®Google Scholar
• Fong K. L., McCay P. B., Poyer J. L., Misra H. P., Keele B. B. Evidence for superoxide-dependent reduction of Fe3+ and its role in enzyme generated hydroxyl radical formation. Chem. Biol. Interac 1976; 15: 77
   PubMed Web of Science ®Google Scholar
• Halliwell B., DeRycker J. Superoxide and peroxidase-catalyzed reactions. Oxidation of dihydroxyfumarate, NADH and dithiothreitol by horseradish peroxidase. Photochem. Photobiol. 1978; 28: 757
   Web of Science ®Google Scholar
• Fee J. A. Superoxide dismutases. Proc. 3rd Symp. Oxidases, Related Redox Syst., T. E. King, H. S. Mason, M. Morrison. Academic Press, New York, in press
   Google Scholar
• Gutteridge J. M. C. Superoxide dismutase (erythrocuprein) and free radicals in clinical chemistry. Ann. Clin. Biochem. 1976; 13: 393
   PubMedGoogle Scholar
• Gutteridge J. M. C. Caeruloplasmin: a plasma protein, enzyme and antioxidant. Ann. Clin. Biochem. 1978; 15: 293
   PubMed Web of Science ®Google Scholar
• Halliwell B., Richmond R., Wong S. F., Gurteridge J. M. C. The biological significance of the Haber-Weiss reaction. Biological and Clinical Aspects of Superoxide and Superoxide Dismutase, W. H. Bannister, J. V. Bannister. Elsevier/North-Holland, Amsterdam 1980
   Google Scholar
• McCord J. M., Wong K. Oxygen Free Radicals and tissue damage in Phagocyte-Produced Free Radicals: Roles in Cytotoxicity and Inflammation. Ciba Symposium, London 1978
   Google Scholar
• McCord J. M., Stokes S. H., Wong K. Oxygen derived products as mediators of inflammation. Proc. Int. Congr. Inflammation, BolognaItaly, November, 1978
   Google Scholar
• Salin M. L., McCord J. M. Free radicals in leucocyte metabolism and inflammation. Superoxide and Superoxide Dismutases, A. M. Michelson, J. M. McCord, I. Fridovich. Academic Press, New York 1977; 257
   Google Scholar